Gamco Investors INC. ET AL purchased a new stake in shares of Invuity Inc (NASDAQ:IVTY) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 52,000 shares of the medical instruments supplier’s stock, valued at approximately $385,000.

Other institutional investors have also added to or reduced their stakes in the company. Fondren Management LP purchased a new stake in Invuity during the second quarter valued at $168,000. Northern Trust Corp raised its stake in Invuity by 32.4% during the second quarter. Northern Trust Corp now owns 45,244 shares of the medical instruments supplier’s stock valued at $176,000 after purchasing an additional 11,073 shares in the last quarter. Spark Investment Management LLC raised its stake in Invuity by 138.2% during the second quarter. Spark Investment Management LLC now owns 45,500 shares of the medical instruments supplier’s stock valued at $177,000 after purchasing an additional 26,400 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Invuity by 5,196.9% during the first quarter. JPMorgan Chase & Co. now owns 47,672 shares of the medical instruments supplier’s stock valued at $184,000 after purchasing an additional 46,772 shares in the last quarter. Finally, BlackRock Inc. raised its stake in Invuity by 43.4% during the second quarter. BlackRock Inc. now owns 56,511 shares of the medical instruments supplier’s stock valued at $221,000 after purchasing an additional 17,091 shares in the last quarter. 55.34% of the stock is currently owned by institutional investors.

IVTY stock opened at $7.39 on Friday. Invuity Inc has a twelve month low of $2.35 and a twelve month high of $9.55.

IVTY has been the topic of a number of recent research reports. Leerink Swann downgraded shares of Invuity from an “outperform” rating to a “market perform” rating in a research note on Wednesday, September 12th. Stifel Nicolaus downgraded shares of Invuity from a “buy” rating to a “hold” rating in a research note on Tuesday, September 11th. ValuEngine downgraded shares of Invuity from a “hold” rating to a “sell” rating in a research note on Thursday, September 6th. Northland Securities downgraded shares of Invuity from an “outperform” rating to a “market perform” rating in a research note on Monday, September 17th. Finally, Piper Jaffray Companies downgraded shares of Invuity from an “overweight” rating to a “neutral” rating in a research note on Tuesday, September 11th. Six investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $5.08.

COPYRIGHT VIOLATION NOTICE: This piece was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2018/11/16/gamco-investors-inc-et-al-buys-new-holdings-in-invuity-inc-ivty.html.

Invuity Company Profile

Invuity, Inc, a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities.

Recommended Story: Reverse Stock Split

Want to see what other hedge funds are holding IVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invuity Inc (NASDAQ:IVTY).

Institutional Ownership by Quarter for Invuity (NASDAQ:IVTY)

Receive News & Ratings for Invuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity and related companies with MarketBeat.com's FREE daily email newsletter.